STAT - Reporting from the frontiers of health and medicine

Subscribe to STAT Plus to join our Sept. 25 webinar: Tips of the trade: How to interpret clinical trial results like a pro. Subscribe Now.

Politics

In the Lab

Biotech

First Opinion Pod mods and vaping are creating a new generation of youths addicted to nicotine
The Readout LOUD LISTEN: A Hong Kong heat-check, a $20 million wrist slap, and pharma’s (other) diversity problem
First Opinion How one pharmaceutical company is reinventing the clinical trial
Health Puppies are making people sick — and it’s people’s fault
Adam's Take Galectin Therapeutics buries bad news in the hype of a combination cancer drug trial

Exclusive analysis of biotech, pharma, and the life sciences

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

A European health insurer sues AstraZeneca over a patent maneuver
‘Stuff floating’ in compounded drugs prompts FDA to appeal for more funding
Generic drug makers face ‘a silent crisis,’ FDA official says, and raising prices could help

Special Report

By Caroline Chen and Riley Wong — ProPublica

In the Lab

By Justin Chen

In the Lab

Health

Health

Adam's Take

First Opinion How one pharmaceutical company is reinventing the clinical trial
Health Puppies are making people sick — and it’s people’s fault
In the Lab Beyond the pale (ale): FDA orders pharma lab to can its microbrewery operation
Special Report Denied ‘life-extending opportunities’: Black patients are being left out of clinical trials amid wave of new cancer therapies
Politics AMA urges Congress not to loosen restrictions on privacy for patients with addiction history